Stock Price Forecast

Aug. 7, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Novan Inc chart...

About the Company

novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.

CEO

Paula Stafford

Exchange

NASDAQ

Website

http://www.novan.com/

$24M

Total Revenue

75

Employees

$2M

Market Capitalization

-0.05

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NOVN News

Warts Therapeutics Market Analysis, Key Segments, Share, Size, Growth Status, and Forecast to 2024 to 2032

9d ago, source: Taiwan News

Report Ocean recently published a research report titled “Warts Therapeutics Market” 2024 Forecast to 2032 Analysis by Market ...

We don't have any news on Novan Inc at the moment.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...